Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Neuroprotective Potential of Carnosine in Cerebrovascular Diseases

Authors
Neelakandan, A. R.Bae, Ok-NamMajid, ArshadBurak, Caglayan A.Rajanikant, G. K.
Issue Date
Jan-2022
Publisher
Springer Verlag
Keywords
Carnosine; Ischemic stroke; Hemorrhagic stroke; Vascular dementia; Neuroprotection
Citation
International Journal of Peptide Research and Therapeutics, v.28, no.1, pp 1 - 12
Pages
12
Indexed
SCIE
SCOPUS
Journal Title
International Journal of Peptide Research and Therapeutics
Volume
28
Number
1
Start Page
1
End Page
12
URI
https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/108035
DOI
10.1007/s10989-021-10342-5
ISSN
1573-3149
1573-3904
Abstract
The growing prevalence, the risk of disabilities, and the lack of effective causal or disease-modifying therapies make cerebrovascular disorders a serious burden. Carnosine, an evolutionarily conserved endogenous dipeptide and over-the-counter food supplement, has a wealth of evidence exhibiting potentially neuroprotective effects. It is a natural, multi-functional, non-toxic anti-glycating antioxidant found in high concentrations in human and mammalian muscle and brain tissues. The physiological presence of carnosine in the brain, ability to cross the blood-brain barrier, and evidence from in vitro, and in vivo studies all point to it as a promising neurotherapeutic agent for cerebrovascular disorders. This review is intended to provide a detailed overview of the neuroprotective role of carnosine in cerebrovascular diseases and summarize existing evidence from cell and animal studies.
Files in This Item
Go to Link
Appears in
Collections
COLLEGE OF PHARMACY > DEPARTMENT OF PHARMACY > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Bae, Ok Nam photo

Bae, Ok Nam
COLLEGE OF PHARMACY (DEPARTMENT OF PHARMACY)
Read more

Altmetrics

Total Views & Downloads

BROWSE